Coerente Capital Management Trims Stock Position in CVS Health Corporation $CVS

Key Points

• Coerente Capital Management cut its stake in CVS by 27.2%, selling 27,914 shares and leaving it with 74,668 shares worth $5.926 million, making CVS its 23rd-largest holding; institutional investors own about 80.66% of the stock.
• Wall Street leans positive: 20 analysts rate CVS a Buy versus 3 Holds, giving an average "Moderate Buy" rating and a consensus price target of $94.95.
• CVS beat Q4 estimates with $1.09 EPS and $105.69 billion revenue, set FY2026 guidance of 5.94–6.14 EPS (analysts expect ~5.89), and declared a quarterly dividend of $0.665 (annualized $2.66, ~3.4% yield).

Coerente Capital Management cut its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 27.2% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 74,668 shares of the pharmacy operator's stock after selling 27,914 shares during the period. CVS Health accounts for 1.1% of Coerente Capital Management's holdings, making the stock its 23rd biggest holding. Coerente Capital Management's holdings in CVS Health were worth $5,926,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Ritholtz Wealth Management boosted its stake in shares of CVS Health by 11.4% during the fourth quarter. Ritholtz Wealth Management now owns 17,759 shares of the pharmacy operator's stock valued at $1,409,000 after purchasing an additional 1,819 shares in the last quarter. Diversify Advisory Services LLC boosted its stake in shares of CVS Health by 8.2% during the fourth quarter. Diversify Advisory Services LLC now owns 19,795 shares of the pharmacy operator's stock valued at $1,556,000 after purchasing an additional 1,494 shares in the last quarter. Carnegie Investment Counsel bought a new position in shares of CVS Health during the fourth quarter valued at approximately $3,864,000. City Holding Co. boosted its stake in shares of CVS Health by 55.4% during the fourth quarter. City Holding Co. now owns 1,517 shares of the pharmacy operator's stock valued at $120,000 after purchasing an additional 541 shares in the last quarter. Finally, Venturi Wealth Management LLC boosted its stake in shares of CVS Health by 6.8% during the fourth quarter. Venturi Wealth Management LLC now owns 5,147 shares of the pharmacy operator's stock valued at $408,000 after purchasing an additional 329 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CVS. TD Cowen reiterated a "buy" rating on shares of CVS Health in a research note on Friday, March 13th. Weiss Ratings reiterated a "hold (c-)" rating on shares of CVS Health in a research note on Monday, December 29th. Leerink Partners restated an "outperform" rating and issued a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. The Goldman Sachs Group raised their target price on shares of CVS Health from $95.00 to $97.00 and gave the company a "buy" rating in a research note on Thursday, February 12th. Finally, Sanford C. Bernstein upgraded shares of CVS Health from a "market perform" rating to an "outperform" rating and raised their target price for the company from $91.00 to $94.00 in a research note on Thursday, March 12th. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, CVS Health currently has an average rating of "Moderate Buy" and a consensus price target of $94.95.

CVS Health Price Performance

Shares of CVS opened at $79.29 on Friday. The company has a market cap of $101.61 billion, a price-to-earnings ratio of 57.45, a price-to-earnings-growth ratio of 0.82 and a beta of 0.51. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The company has a 50 day moving average of $75.92 and a two-hundred day moving average of $77.79.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.00 by $0.09. The business had revenue of $105.69 billion during the quarter, compared to analysts' expectations of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business's quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter last year, the company posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, April 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health's dividend payout ratio (DPR) is currently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.